X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6485) 6485
Book Review (1180) 1180
Publication (393) 393
Book Chapter (73) 73
Dissertation (42) 42
Conference Proceeding (21) 21
Book / eBook (2) 2
Journal / eJournal (2) 2
Magazine Article (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4301) 4301
hmg-coa reductase (3415) 3415
humans (2860) 2860
animals (1919) 1919
male (1656) 1656
statins (1496) 1496
cholesterol (1406) 1406
pharmacology & pharmacy (1337) 1337
female (1135) 1135
biochemistry & molecular biology (1054) 1054
hmg-coa reductase inhibitors (932) 932
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (921) 921
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (899) 899
simvastatin (885) 885
middle aged (773) 773
coenzyme-a reductase (762) 762
rats (746) 746
hmg-coa reductase inhibitor (650) 650
pravastatin (649) 649
hypercholesterolemia (603) 603
atherosclerosis (590) 590
atorvastatin (568) 568
lovastatin (562) 562
adult (559) 559
aged (558) 558
hydroxymethylglutaryl coa reductases - metabolism (547) 547
cholesterol - blood (518) 518
lipids (469) 469
mice (451) 451
cholesterol - metabolism (441) 441
low-density-lipoprotein (422) 422
cardiac & cardiovascular systems (409) 409
metabolism (404) 404
peripheral vascular disease (399) 399
risk factors (389) 389
atorvastatin calcium (369) 369
research (359) 359
inhibitors (354) 354
statin (351) 351
enzymes (347) 347
hypercholesterolemia - drug therapy (344) 344
cell biology (343) 343
medicine & public health (342) 342
liver - metabolism (336) 336
in-vitro (330) 330
coronary-heart-disease (328) 328
lovastatin - pharmacology (315) 315
dose-response relationship, drug (314) 314
physiological aspects (312) 312
cholesterol, ldl - blood (307) 307
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (307) 307
anticholesteremic agents - therapeutic use (302) 302
expression (294) 294
analysis (288) 288
cells, cultured (287) 287
liver (287) 287
cholesterol - biosynthesis (285) 285
prevention (277) 277
oncology (274) 274
anticholesteremic agents - pharmacology (270) 270
hydroxymethylglutaryl coa reductases - genetics (266) 266
rats, sprague-dawley (264) 264
risk (261) 261
pharmacology/toxicology (260) 260
simvastatin - pharmacology (260) 260
therapy (256) 256
hydroxymethylglutaryl-coa reductase inhibitors (254) 254
nitric-oxide synthase (254) 254
lipids - blood (252) 252
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (251) 251
biosynthesis (250) 250
apoptosis (248) 248
drug interactions (241) 241
mevalonate pathway (240) 240
medicine, research & experimental (237) 237
hmg coa reductase (234) 234
treatment outcome (231) 231
inflammation (230) 230
triglycerides - blood (229) 229
cells (227) 227
cancer (224) 224
hmg coa reductase inhibitors (224) 224
hyperlipidemia (221) 221
biophysics (220) 220
liver - drug effects (218) 218
time factors (218) 218
drug therapy (217) 217
c-reactive protein (215) 215
endocrinology & metabolism (214) 214
health aspects (214) 214
hyperlipidemias - drug therapy (213) 213
nutrition & dietetics (212) 212
coa reductase inhibitors (208) 208
fluvastatin (208) 208
proteins (207) 207
pravastatin - pharmacology (202) 202
inhibitor (200) 200
heptanoic acids - pharmacology (194) 194
abridged index medicus (192) 192
medicine, general & internal (192) 192
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6283) 6283
German (91) 91
Japanese (65) 65
French (36) 36
Chinese (31) 31
Korean (31) 31
Spanish (26) 26
Portuguese (12) 12
Russian (12) 12
Italian (4) 4
Turkish (4) 4
Czech (2) 2
Polish (2) 2
Slovenian (2) 2
Catalan (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 10, pp. 1200 - 1210
Abstract Background Statins are first-line therapy for cardiovascular disease prevention, but their systemic effects across lipoprotein subclasses, fatty... 
Cardiovascular | Internal Medicine | drug development | Mendelian randomization | metabolomics | cholesterol lowering | lipoproteins | COHORT PROFILE | CARDIAC & CARDIOVASCULAR SYSTEMS | BIOMARKER | VARIANTS | FATTY-ACID-COMPOSITION | RISK | TRIGLYCERIDES | LDL CHOLESTEROL | CORONARY-HEART-DISEASE | ASSOCIATION | EPIDEMIOLOGY | Hydroxymethylglutaryl CoA Reductases - drug effects | Mendelian Randomization Analysis - methods | Magnetic Resonance Spectroscopy - methods | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | United Kingdom | Cardiovascular Diseases - genetics | Forecasting | Metabolomics - methods | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Finland | Cardiovascular Diseases - blood | Adult | Female | Retrospective Studies | Hydroxymethylglutaryl CoA Reductases - blood | Hydroxymethylglutaryl CoA Reductases - genetics | Medical colleges | Metabolites | Pharmacy | Genomics | Genetic research | Drugstores | Fatty acids | Epidemiology | Statins | Public health | Cardiovascular agents | Lipids | Cholesterol | Index Medicus | Abridged Index Medicus | LDL-C, low-density lipoprotein cholesterol | CVD, cardiovascular disease | IDL, intermediate-density lipoprotein | VLDL, very-low-density lipoprotein | HMGCR, HMG-CoA reductase | NMR, nuclear magnetic resonance | HDL, high-density lipoprotein | Original Investigation
Journal Article
Cancer Research, ISSN 0008-5472, 03/2011, Volume 71, Issue 6, pp. 2286 - 2297
Journal Article
Hypertension, ISSN 0194-911X, 08/2007, Volume 50, Issue 2, pp. 377 - 383
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 10/2015, Volume 466, Issue 3, pp. 536 - 540
Journal Article
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 01/2017, Volume 118, Issue 1, pp. 52 - 57
Plant based bio‐active compound like rutin could be developed as a potential hypo‐cholesterolemic drug and it might serve as a good alternative to statins. 
HMG‐CoA REDUCTASE | DOCKING | PLANT PRODUCTS | MOLECULAR DYNAMICS SIMULATION | HMG-CoA REDUCTASE | Rutin - chemistry | Molecular Docking Simulation | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Hydroxymethylglutaryl CoA Reductases - chemistry | Humans | Molecular dynamics | Physiological aspects | Analysis | Index Medicus
Journal Article
Pest Management Science, ISSN 1526-498X, 09/2017, Volume 73, Issue 9, pp. 1944 - 1952
Journal Article
Journal Article
Journal Article
Journal Article
Chemometrics and Intelligent Laboratory Systems, ISSN 0169-7439, 01/2015, Volume 140, pp. 102 - 116
Journal Article
Tetrahedron Letters, ISSN 0040-4039, 06/2017, Volume 58, Issue 26, pp. 2614 - 2617
During the process development for multistep synthesis of Rosuvastatin calcium several impurities were obtained along with the final Rosuvastatin calcium. Out... 
Rosuvastatin calcium | Drug impurities | HMG-CoA reductase inhibitor | β-Hydroxy sulfonamide | Statins | THERAPY | EFFICACY | SAFETY | BIOLOGICAL-ACTIVITY | CHEMISTRY, ORGANIC | beta-Hydroxy sulfonamide | HYPERCHOLESTEROLEMIA | HYPERTRIGLYCERIDEMIA | Antilipemic agents | Drugstores | Rosuvastatin | Sulfonamides | Pharmacy
Journal Article